Objective:To establish that the Hong Kong Special Administrative Region(HKSAR)government is actively promoting Chinese medicine(CM)and to examine turnover rate of Chinese medicine practitioners(CMPs)in Hong Kong,China...Objective:To establish that the Hong Kong Special Administrative Region(HKSAR)government is actively promoting Chinese medicine(CM)and to examine turnover rate of Chinese medicine practitioners(CMPs)in Hong Kong,China in light of this governmental push.Methods:This study covered two major areas:reviewing CM development in Hong Kong,and assessing the turnover rate of CMPs in Hong Kong.The first part of the paper is a historical review.The investigation of turnover rate had two sections.Section 1,quantitative method,involved online questionnaires;Section 2,qualitative method comprised interviews with CMPs from different types of CM clinics to ascertain the reasons for the turnover among CMPs.Results:A total of 123 online questionnaires were received in Section 1(55 from male CMPs;66 from female CMPs;2 respondents were unwilling to disclose their sex).The proportion of CMPs who had resigned in 2018e19 was 22.8%(28),of whom 5.7%(7)had resigned twice in one year.The rates of resignation in 3 years and 5 years were up to 40.7%(50)and 56.9%(70),respectively.Six CMPs were interviewed in Section 2.Young CMPs were more likely to resign than seniors.The large gap between actual salary and expectations appeared to be the main reason for the high rate of resignation.Conclusion:HKSAR government keenly desires to promote CM in Hong Kong,however,high turnover rate of CMPs was detected even under this positive governmental support.There is an urgent need to conduct a more representative study of the reasons for the inclination of CMPs in Hong Kong.The study highlights an important issue in CM development,and these results should remind different stakeholders in the CM industry and the government that CMPs need better career prospects and support in various areas.展开更多
Within the public health sector of Hong Kong(China),there is a consensus around the important role of traditional Chinese medicines.For Hong Kong(China)to play a bridging role to bring Chinese medicines to the global ...Within the public health sector of Hong Kong(China),there is a consensus around the important role of traditional Chinese medicines.For Hong Kong(China)to play a bridging role to bring Chinese medicines to the global market requires a concerted effort from the government,academic institutes and industries.The release of the final version of the European Medicines Agencies guidance document,which details the acceptance of minimum requirements to nonclinical package in bibliographical applications,grants the opportunity for well-established and traditional herbal medicines to demonstrate an‘acceptable safe’status for registration in the European Union.It is anticipated that this minimum nonclinical package can be applied to demonstrate the safe use of many traditional Chinese medicines regardless of their eligibility to be registered under the simplified procedure within the European Union.This paper conceptualizes an integration of a simplified evaluation route for eligible proprietary Chinese medicines(pCm)with long history of use into the existing drug regulatory framework in Hong Kong(China).Such integration utilizing the minimum nonclinical package,based on bibliographical data or expert report,as proof of evidence to demonstrate safety for pCm with long history of use requires less demand in scientific resources.With Hong Kong(China)conducting‘first hand’review for eligible pCm,it provides an option for overseas and local pharmaceutical companies to register their products in Hong Kong(China)without the need to rely on issuance of Certificate of Pharmaceutical Product from other countries.This could bring eligible pCm with long history of use to reach international risk-based standard and to be marketed globally as‘medicines’to reach their full therapeutic potential.An important process to positioning Hong Kong(China)to compete with other countries in promoting importation and exportation of pCm to better serve the global health.展开更多
In this review, we provide a comprehensive overview on the registration of proprietary Chinese medicines(PCMs) in China over the past century by examining published literature and historical data. We will examine this...In this review, we provide a comprehensive overview on the registration of proprietary Chinese medicines(PCMs) in China over the past century by examining published literature and historical data. We will examine this evolving administrative practice for PCMs registration in China, which is divided to the following five stages:(1) initial measures(1915-1948);(2) early development(1949-1965);(3) provincial approval and trial implementation of the "approval number" system(1966-1984);(4) legislation and cleanup(1985-1999); and(5) centralized national approval(2000 until now), offering a panoramic view on the characteristics of PCMs registration management in China.展开更多
The European Congress for Integrative Medicine 2015 Global Summit on Integrative Medicine and Healthcare in Greater Copenhagen has successfully promoted integrative medicine to the public once again. Integrative medic...The European Congress for Integrative Medicine 2015 Global Summit on Integrative Medicine and Healthcare in Greater Copenhagen has successfully promoted integrative medicine to the public once again. Integrative medicine, which is called the art and science of healthcare by Nordic Integrative Medicine, has been widely used in the world. In Hong Kong, integrated traditional Chinese and Western medicine, which is also known as the Chinese version of integrative medicine, provides a valuable reference for the development of integrative medicine in the world. In this article, we introduce the development of traditional Chinese medicine in Hong Kong and an integrated traditional Chinese and Western medicine model in the University of Hong Kong-Shenzhen Hospital.展开更多
The School of Chinese Medicine, the University of Hong Kong has organized the 7th Pong Ding Yuen International Symposium on Traditional Chinese Medicine cum the 10th Anniversary of the Full-time Bachelor of Chinese Me...The School of Chinese Medicine, the University of Hong Kong has organized the 7th Pong Ding Yuen International Symposium on Traditional Chinese Medicine cum the 10th Anniversary of the Full-time Bachelor of Chinese Medicine Programme on 1 December, 2012, and 2 December, 2012, in Li Ka Shing Faculty of Medicine, the University of Hong Kong.展开更多
文摘Objective:To establish that the Hong Kong Special Administrative Region(HKSAR)government is actively promoting Chinese medicine(CM)and to examine turnover rate of Chinese medicine practitioners(CMPs)in Hong Kong,China in light of this governmental push.Methods:This study covered two major areas:reviewing CM development in Hong Kong,and assessing the turnover rate of CMPs in Hong Kong.The first part of the paper is a historical review.The investigation of turnover rate had two sections.Section 1,quantitative method,involved online questionnaires;Section 2,qualitative method comprised interviews with CMPs from different types of CM clinics to ascertain the reasons for the turnover among CMPs.Results:A total of 123 online questionnaires were received in Section 1(55 from male CMPs;66 from female CMPs;2 respondents were unwilling to disclose their sex).The proportion of CMPs who had resigned in 2018e19 was 22.8%(28),of whom 5.7%(7)had resigned twice in one year.The rates of resignation in 3 years and 5 years were up to 40.7%(50)and 56.9%(70),respectively.Six CMPs were interviewed in Section 2.Young CMPs were more likely to resign than seniors.The large gap between actual salary and expectations appeared to be the main reason for the high rate of resignation.Conclusion:HKSAR government keenly desires to promote CM in Hong Kong,however,high turnover rate of CMPs was detected even under this positive governmental support.There is an urgent need to conduct a more representative study of the reasons for the inclination of CMPs in Hong Kong.The study highlights an important issue in CM development,and these results should remind different stakeholders in the CM industry and the government that CMPs need better career prospects and support in various areas.
文摘Within the public health sector of Hong Kong(China),there is a consensus around the important role of traditional Chinese medicines.For Hong Kong(China)to play a bridging role to bring Chinese medicines to the global market requires a concerted effort from the government,academic institutes and industries.The release of the final version of the European Medicines Agencies guidance document,which details the acceptance of minimum requirements to nonclinical package in bibliographical applications,grants the opportunity for well-established and traditional herbal medicines to demonstrate an‘acceptable safe’status for registration in the European Union.It is anticipated that this minimum nonclinical package can be applied to demonstrate the safe use of many traditional Chinese medicines regardless of their eligibility to be registered under the simplified procedure within the European Union.This paper conceptualizes an integration of a simplified evaluation route for eligible proprietary Chinese medicines(pCm)with long history of use into the existing drug regulatory framework in Hong Kong(China).Such integration utilizing the minimum nonclinical package,based on bibliographical data or expert report,as proof of evidence to demonstrate safety for pCm with long history of use requires less demand in scientific resources.With Hong Kong(China)conducting‘first hand’review for eligible pCm,it provides an option for overseas and local pharmaceutical companies to register their products in Hong Kong(China)without the need to rely on issuance of Certificate of Pharmaceutical Product from other countries.This could bring eligible pCm with long history of use to reach international risk-based standard and to be marketed globally as‘medicines’to reach their full therapeutic potential.An important process to positioning Hong Kong(China)to compete with other countries in promoting importation and exportation of pCm to better serve the global health.
文摘In this review, we provide a comprehensive overview on the registration of proprietary Chinese medicines(PCMs) in China over the past century by examining published literature and historical data. We will examine this evolving administrative practice for PCMs registration in China, which is divided to the following five stages:(1) initial measures(1915-1948);(2) early development(1949-1965);(3) provincial approval and trial implementation of the "approval number" system(1966-1984);(4) legislation and cleanup(1985-1999); and(5) centralized national approval(2000 until now), offering a panoramic view on the characteristics of PCMs registration management in China.
文摘The European Congress for Integrative Medicine 2015 Global Summit on Integrative Medicine and Healthcare in Greater Copenhagen has successfully promoted integrative medicine to the public once again. Integrative medicine, which is called the art and science of healthcare by Nordic Integrative Medicine, has been widely used in the world. In Hong Kong, integrated traditional Chinese and Western medicine, which is also known as the Chinese version of integrative medicine, provides a valuable reference for the development of integrative medicine in the world. In this article, we introduce the development of traditional Chinese medicine in Hong Kong and an integrated traditional Chinese and Western medicine model in the University of Hong Kong-Shenzhen Hospital.
文摘The School of Chinese Medicine, the University of Hong Kong has organized the 7th Pong Ding Yuen International Symposium on Traditional Chinese Medicine cum the 10th Anniversary of the Full-time Bachelor of Chinese Medicine Programme on 1 December, 2012, and 2 December, 2012, in Li Ka Shing Faculty of Medicine, the University of Hong Kong.